{
    "organizations": [],
    "uuid": "4c3bafdd2eae028cf4cf1f08cea2e2dd16598a73",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ascentage-pharma-announces-accepta/brief-ascentage-pharma-announces-acceptance-of-ind-application-by-china-fda-idUSASB0C01M",
    "ord_in_thread": 0,
    "title": "BRIEF-Ascentage Pharma Announces Acceptance Of IND Application By China FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) -\n* ASCENTAGE PHARMA ANNOUNCES ACCEPTANCE OF IND APPLICATION BY CHINA FDA FOR CLINICAL STUDY OF NOVEL IAP INHIBITOR TO TREAT HEPATITIS B INFECTION Source text for Eikon:\n ",
    "published": "2018-01-08T20:08:00.000+02:00",
    "crawled": "2018-01-09T17:14:09.042+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "ascentage",
        "pharma",
        "announces",
        "acceptance",
        "ind",
        "application",
        "china",
        "fda",
        "clinical",
        "study",
        "novel",
        "iap",
        "inhibitor",
        "treat",
        "hepatitis",
        "b",
        "infection",
        "source",
        "text",
        "eikon"
    ]
}